Is PET-CT suitable for predicting lymph node status for gastric cancer?
Qiu-Meng Yang1, Taiichi Kawamura, Hiroaki Itoh
1Department of Gastric Surgery, and Peritoneal Dissemination, Shizuoka Cancer Center, Japan.
Hepato-Gastroenterology
|July 11, 2008
Summary
Positron emission tomography-computed tomography (PET-CT) is not sufficiently sensitive for preoperative prediction of lymph node status in gastric cancer. Computed tomography (CT) demonstrated better sensitivity in identifying metastatic lymph nodes.
Area of Science:
- Oncology
- Radiology
- Surgical Oncology
Background:
- Accurate preoperative staging of gastric cancer is crucial for treatment planning.
- Lymph node metastasis significantly impacts patient prognosis and treatment strategies.
- Evaluating the efficacy of imaging modalities for lymph node staging is essential.
Purpose of the Study:
- To assess the diagnostic value of PET-CT in predicting lymph node status in gastric cancer patients before surgery.
- To compare the performance of PET-CT with conventional CT for lymph node staging.
Main Methods:
- A study involving 78 gastric cancer patients who underwent preoperative PET-CT.
- Comparison of PET-CT lymph node status results with postoperative pathological findings.
- Utilizing CT as a control imaging modality for comparison.
Main Results:
- PET-CT showed an accuracy of 55.1% for N category staging, compared to 54.4% for CT.
- PET-CT had lower sensitivity (31.0%) than CT (60.5%) in predicting positive lymph nodes, although specificity was higher (97.2% vs. 83.3%).
- CT demonstrated significantly better sensitivity (p = 0.031) for detecting tier 1 lymph node metastasis compared to PET-CT.
Conclusions:
- PET-CT exhibits insufficient sensitivity for the preoperative prediction of regional lymph node status in gastric cancer.
- Conventional CT, despite its limitations, offers superior sensitivity for detecting lymph node metastasis in gastric cancer.
